hydroxychloroquine has been researched along with Osteopoikilosis in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Osteopoikilosis: An asymptomatic, autosomal dominant trait in which pea-sized sclerotic spots, prominent in the metaphyseal area, are accompanied by unique cutaneous lesions. These are yellowish papules or plaques with increased elastin content. (From Cecil Textbook of Medicine, 19th ed, pp1434-35)
Excerpt | Relevance | Reference |
---|---|---|
"Osteopoikilosis is an uncommon, benign sclerosing bone dysplasia characterised by typical roentgenographic findings and usually seen in patients with dermatological problems." | 1.31 | Coexistence of osteopoikilosis and discoid lupus erythematosus: a case report. ( Bicer, A; Dusmez, D; Ikizoglu, G; Kaya, TI; Ozer, C; Tursen, U, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bicer, A | 1 |
Tursen, U | 1 |
Ozer, C | 1 |
Kaya, TI | 1 |
Dusmez, D | 1 |
Ikizoglu, G | 1 |
1 other study available for hydroxychloroquine and Osteopoikilosis
Article | Year |
---|---|
Coexistence of osteopoikilosis and discoid lupus erythematosus: a case report.
Topics: Adult; Blood Chemical Analysis; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Hydroxyc | 2002 |